Volume 6, Issue 4, Pages (April 1997)

Slides:



Advertisements
Similar presentations
Volume 11, Issue 5, Pages (May 2004)
Advertisements

Volume 14, Issue 6, Pages (June 2001)
A novel SHP-1/Grb2–dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling.
Roles of JAK kinases in human GM-CSF receptor signal transduction
Volume 9, Issue 5, Pages (November 1998)
Roles of the cytoplasmic domains of the α and β subunits of human granulocyte- macrophage colony-stimulating factor receptor  Akihiko Muto, PhDa, Sumiko.
Federico Dajas-Bailador, Emma V. Jones, Alan J. Whitmarsh 
Large Hepatitis Delta Antigen Modulates Transforming Growth Factor-β Signaling Cascades: Implication of Hepatitis Delta Virus–Induced Liver Fibrosis 
by Fan Dong, and Andrew C. Larner
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Regulation of Mast Cell Survival by IgE
Lyn Physically Associates With the Erythropoietin Receptor and May Play a Role in Activation of the Stat5 Pathway by Hiroshi Chin, Ayako Arai, Hiroshi.
Volume 125, Issue 3, Pages (September 2003)
Differential influence of tyrosine residues of the common receptor β subunit on multiple signals induced by human GM-CSF  Tohru Itoh, PhD, Rui Liu, MSc,
Volume 8, Issue 5, Pages (November 2001)
Volume 5, Issue 4, Pages (April 2004)
Volume 33, Issue 2, Pages (January 2009)
Autoinhibition of c-Abl
Substance P Enhances the Production of Interferon-induced Protein of 10 kDa by Human Keratinocytes in Synergy with Interferon-γ  Naoko Kanda, Shinichi.
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Estela Jacinto, Guy Werlen, Michael Karin  Immunity 
Volume 87, Issue 7, Pages (December 1996)
Arginine Methylation of STAT1 Modulates IFNα/β-Induced Transcription
ASK1 Is Essential for JNK/SAPK Activation by TRAF2
Volume 7, Issue 2, Pages (February 2001)
Volume 4, Issue 4, Pages (April 1996)
Identification and Characterization of an IκB Kinase
The Kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt- mediated phosphorylation of Bad on Ser136  Peter Blume-Jensen,
Volume 4, Issue 1, Pages (January 1996)
Grb2 Is a Key Mediator of Helicobacter pylori CagA Protein Activities
Volume 9, Issue 5, Pages (November 1998)
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
MADR1, a MAD-Related Protein That Functions in BMP2 Signaling Pathways
Robert L.S Perry, Maura H Parker, Michael A Rudnicki  Molecular Cell 
17β-Estradiol Inhibits MCP-1 Production in Human Keratinocytes
MyD88: An Adapter That Recruits IRAK to the IL-1 Receptor Complex
Monika Raab, Antonio J.da Silva, Paul R. Findell, Christopher E. Rudd 
Volume 4, Issue 2, Pages (February 1996)
Volume 10, Issue 6, Pages (December 2006)
Regulation of Mast Cell Survival by IgE
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Upregulation of Tenascin-C Expression by IL-13 in Human Dermal Fibroblasts via the Phosphoinositide 3-kinase/Akt and the Protein Kinase C Signaling Pathways 
Histamine Inhibits the Production of Interferon-induced Protein of 10 kDa in Human Squamous Cell Carcinoma and Melanoma  Naoko Kanda, Shinichi Watanabe 
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Cyclooxygenase-2 Inhibitor Enhances Whereas Prostaglandin E2Inhibits the Production of Interferon-Induced Protein of 10 kDa in Epidermoid Carcinoma A431 
Volume 7, Issue 4, Pages (April 2001)
Yongsheng Ma, Eric Carter, Xiaomei Wang, Chang Shu 
Per Stehmeier, Stefan Muller  Molecular Cell 
Volume 11, Issue 5, Pages (November 1999)
Activated Cdc42 Sequesters c-Cbl and Prevents EGF Receptor Degradation
Volume 10, Issue 5, Pages (November 2002)
Volume 20, Issue 2, Pages (February 2004)
Volume 116, Issue 6, Pages (June 1999)
Roles of the cytoplasmic domains of the α and β subunits of human granulocyte- macrophage colony-stimulating factor receptor  Akihiko Muto, PhDa, Sumiko.
Volume 86, Issue 5, Pages (September 1996)
TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways  Hailing Hsu, Hong-Bing Shu, Ming-Gui Pan, David.
Volume 6, Issue 4, Pages (October 2000)
Silva H Hanissian, Raif S Geha  Immunity 
Hua Gao, Yue Sun, Yalan Wu, Bing Luan, Yaya Wang, Bin Qu, Gang Pei 
Livio Trusolino, Andrea Bertotti, Paolo M Comoglio  Cell 
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Volume 9, Issue 5, Pages (November 1998)
Volume 4, Issue 4, Pages (October 1999)
Grb2 Is a Key Mediator of Helicobacter pylori CagA Protein Activities
Volume 129, Issue 5, Pages (June 2007)
Volume 22, Issue 3, Pages (May 2006)
Volume 12, Issue 6, Pages (March 2002)
Volume 10, Issue 2, Pages (February 1999)
Volume 31, Issue 5, Pages (September 2008)
Volume 14, Issue 6, Pages (June 2001)
Presentation transcript:

Volume 6, Issue 4, Pages 449-457 (April 1997) STAM, Signal Transducing Adaptor Molecule, Is Associated with Janus Kinases and Involved in Signaling for Cell Growth and c-myc Induction  Toshikazu Takeshita, Tomikazu Arita, Masaya Higuchi, Hironobu Asao, Kazuhiro Endo, Hiroshi Kuroda, Nobuyuki Tanaka, Kazuko Murata, Naoto Ishii, Kazuo Sugamura  Immunity  Volume 6, Issue 4, Pages 449-457 (April 1997) DOI: 10.1016/S1074-7613(00)80288-5

Figure 1 IL-2-Induced Tyrosine Phosphorylation of STAM in MOLT4 Transfectants with the Wild Type and Mutants of the IL-2 Receptor β Chain (A) The schematic structures of the wild-type (wild), A mutant (dA), box1 mutant (79S), and S mutant (dS) of the human IL-2 receptor β chain are shown. The shaded boxes indicate transmembrane domains. The A mutant and S mutant are deleted from the acidic region (Gln-313–Leu-382) and serine-rich region (Ser-267–Ser-322), respectively. The box1 mutant contains substitution of Pro-257 and Pro-259 for serines. (B) MOLT4 transfectants with the wild-type, A mutant, box1 mutant, and S mutant of the human IL-2 receptor β chain were incubated with (plus) or without (minus) 10 nM human recombinant IL-2 for 10 min. The cell lysates were lysed, and the lysates were immunoprecipitated with anti-STAM MAb, TUS-1, which was prepared against the glutathione S-transferase (GST) fusion protein of human STAM (amino acid positions 139–222). The immunoprecipitates were separated by SDS–PAGE and blotted with anti-phosphotyrosine MAb or TUS-1. Arrowheads indicate STAM. Immunity 1997 6, 449-457DOI: (10.1016/S1074-7613(00)80288-5)

Figure 2 Tyrosine Phosphorylation of STAM by Jak Family Tyrosine Kinases Simian fibroblastoid COS7 cells were transiently transfected with 10 μg of DNA of Jak3, Jak2, Jak1, Lck, or pEF-BOS control plasmid together with 10 μg of DNA of human IL-2 receptor β and γc plasmids (A) and 10 μg of DNA of human GM-CSF receptor α and βc plasmids (B), in addition to 10 μg of DNA of pCXSTAM by electroporation. The cells were preincubated for 24 hr and stimulated with IL-2 (A) and GM-CSF (B) for 10 min. Subsequently, the cells were immunoprecipitated with anti-STAM MAb (TUS-1) and then immunoblotted with anti-phosphotyrosine MAb (4G10) or anti-STAM MAb. Arrowheads indicate the wild-type STAM. Immunity 1997 6, 449-457DOI: (10.1016/S1074-7613(00)80288-5)

Figure 3 Tyrosine Phosphorylation of the Wild Type and STAM Mutants by Jak3 and Jak2 Kinases (A) Schematic structures of the wild type and mutants of STAM. DSH3, DIT, and DY2 mutants of STAM are deleted of the SH3 domain (Ala-217–Ala-266), ITAM (Glu-356–Leu-387), and tyrosine cluster region (Tyr-371–Leu-540), respectively. The closed boxes, shaded boxes, and Y letters indicate the SH3 domain, ITAM, and tyrosine residues, respectively. (B and C) COS7 cells were transiently transfected with 10 μg of DNA each of pCXSTAM, pCXDSH3, pCXDIT, or pCXDY2, together with a combination of 10 μg of DNA of human IL-2 receptor β and γc plasmids and 10 μg of DNA of Jak3 or pSRa (control plasmid) or, in (C), a combination of 10 μg of DNA of human GM-CSF receptor α and βc plasmids and 10 μg of DNA of Jak2 or pEF-BOS (control plasmid) by electroporation. The cells were preincubated for 24 hr and stimulated with IL-2 (B) and GM-CSF (C) for 10 min. Subsequently, the cells were immunoprecipitated with anti-STAM MAb (TUS-1) and then immunoblotted with anti-phosphotyrosine MAb (4G10) (upper panels) or TUS-1 (lower panels). Immunity 1997 6, 449-457DOI: (10.1016/S1074-7613(00)80288-5)

Figure 4 Coimmunoprecipitation of Endogenous STAM with Jak3 and Jak2 Kinases A human IL-2-dependent T cell line, ILT-Mat, was incubated with (plus) or without (minus) 10 nM IL-2 for 10 min. Lysates of the ILT-Mat cells (2.5 × 107) were immunoprecipitated with anti-STAM, anti-B19 human parvovirus as a control, and anti-Jak1 MAbs, or lysates of the ILT-Mat cells (2.5 × 106) were immunoprecipitated with anti-Jak3, anti-Jak2, anti-Syk, and anti-Lck antibodies. The immunoprecipitates were then separated by SDS–PAGE and immunoblotted with anti-Jak3, anti-Jak2, anti-Jak1, anti-Syk, and anti-Lck antibodies. Arrowheads indicate Jak3, Jak2, Jak1, Syk, and Lck, respectively. Immunity 1997 6, 449-457DOI: (10.1016/S1074-7613(00)80288-5)

Figure 5 Coimmunoprecipitation of the Wild Type and STAM Mutants with Jak3 and Jak2 COS7 cells were transiently transfected with 10 μg of DNA each of pCXSTAM, pCXDSH3, pCXDIT, or pCXDY2, together with 10 μg of DNA of Jak3, Jak2, or control plasmids by electroporation. The cells were incubated for 24 hr, and their lysates were immunoprecipitated with anti-STAM MAb and then immunoblotted with anti-Jak3, anti-Jak2, and anti-STAM antibodies (A and B). Alternatively, their lysates were immunoprecipitated with anti-Jak3 and anti-Jak2 antibodies and then immunoblotted with anti-STAM, anti-Jak3, and anti-Jak2 antibodies (C and D). Immunity 1997 6, 449-457DOI: (10.1016/S1074-7613(00)80288-5)

Figure 6 Effect of STAM on [3H]Thymidine Incorporation of BAF-BO3 Cells in Response to IL-2 and GM-CSF BAF-B03 cells maintained in the medium containing IL-3 were transiently transfected with 10 μg of DNA each of pCXSTAM, pCXDSH3, pCXDIT, pCXDY2, or pCXN2 (control plasmid) (A and C) or with combinations of the indicated DNA doses of pCXDSH3 and pCXN2 (B and D), together with 2 μg of DNA of human IL-2 receptor β and γc plasmids (A and B) or 2 μg of DNA of human GM-CSF receptor α and βc plasmids (C and D) by electroporation. Subsequently, the cells were cultured for 24 hr with (plus) or without (minus) IL-2 (A and B) in the presence of anti-mouse IL-2 receptor α chain (PC61) and β chain (TUm122) MAbs, or with (plus) or without (minus) GM-CSF (C and D), in RPMI 1640 medium containing 0.01% BSA, and assayed for [3H]thymidine incorporation for the last 4 hr of cultivation. The values shown are means ± SEM of triplicate cultures. Results represent one of three comparable experiments. Immunity 1997 6, 449-457DOI: (10.1016/S1074-7613(00)80288-5)

Figure 7 Effect of STAM on Induction of c-myc in Response to IL-2 and GM-CSF BAF-B03 cells starved of IL-3 and FCS for 9 hr were transfected with pCXSTAM, pCXDSH3, pCXDIT, pCXDY2, and pCXN2 (A and C) or with combinations of pCXSTAM and pCXN2 (B and D), together with human IL-2 receptor β and γc plasmids (A and B) or together with human GM-CSF receptor α and βc plasmids (C and D), in addition to pHXLuc and pENL by electroporation. Subsequently, the cells were stimulated with (plus) or without (minus) human recombinant IL-2 in the presence of anti-mouse IL-2 receptor α chain (PC61) and β chain (TUm122) MAbs (A and B), or with (plus) or without (minus) human recombinant GM-CSF (C and D), in RPMI 1640 medium containing 0.01% BSA for 11 hr, and assayed for luciferase activity. The luciferase activities were displayed after correction of protein concentration and β-galactosidase activity of cell lysates. The values shown are means ± SEM of triplicate determinants. Results represent one of three comparable experiments. Immunity 1997 6, 449-457DOI: (10.1016/S1074-7613(00)80288-5)